23andMe Holding Registered (A) ISIN: US90138Q3065

"In July 2020, 23andMe and GlaxoSmithKline announced their partnership's first clinical trial: a joint asset being co-developed by the two companies for cancer treatment.[29] In December 2020, the company raised around $82.5 million in a series F round, bringing the total raised over the years to over $850M. The post-money valuation was not reported.[30] In February 2021, the company announced that it had entered into a definitive agreement to merge with Sir Richard Branson's special-purpose acquisition company, VG Acquisition Corp, in a $3.5 billion transaction.[31] In June 2021, the company completed the merger with VG Acquisition Corp." ---- hört sich irgendwie so an als wäre die Zusammenarbeit mit GSK noch erfolgreich gewesen und mit dem Virgin-Merger haben sie sich dann irgendwie übernommen.